Sign In

Ilya Budik

CEO of CardioRenal Systems, Active Kidney Protection

Ilya Budik is the CEO of CardioRenal Systems Inc. (RenalGuard), a company developing clinically validated solutions for preventing Acute Kidney Injury (AKI).1 He has been in this role since November 2021.2 Budik has a diverse background in healthcare and business:

Professional Experience

  • CEO at CardioRenal Systems Inc. (RenalGuard) since November 20212
  • Managing Partner at Imagine Bio, advising healthcare leaders on strategy and investments12
  • Former CEO of NeuroQuest, leading the development of diagnostic tests for Alzheimer's and ALS12
  • Previously held roles in business development at MND Diagnostic Ltd. and global finance at Ethicon Endo-Surgery12

Education

  • Degrees in Finance and Biochemistry from Miami University12
  • Specialized training in Healthcare Entrepreneurship from Tel Aviv University1

Achievements

  • Led RenalGuard Therapy to receive FDA Breakthrough Device Designation in January 202334
  • Oversees the development of RenalGuard Therapy, which has shown a 52% reduction in AKI compared to standard care in clinical trials24

Budik is known for his expertise in healthcare innovation, business development, and strategic management in the medical device industry.5

Related Questions

What inspired Ilya Budik to transition from global finance to healthcare entrepreneurship?
How did Ilya Budik's experience at NeuroQuest influence his leadership style at CardioRenal Systems?
What are the key challenges Ilya Budik has faced in developing RenalGuard Therapy?
How does Ilya Budik's background in biochemistry contribute to his role at CardioRenal Systems?
What strategies has Ilya Budik implemented at Imagine Bio to advise healthcare leaders?
Ilya Budik
Ilya Budik, photo 1
Ilya Budik, photo 2
Add to my network

Location

Greater Boston